Upcoming IPO Dr. Agarwal’s Health Care Ltd in January 2025

 Upcoming IPO Dr. Agarwal’s Health Care Ltd in January 2025 Full Information. 

Dr. Agarwal’s Health Care Ltd (DAHCL) is a leading healthcare provider in India, primarily focusing on ophthalmology, including eye care, cataract surgery, and other related services. The company has a well-established presence with numerous eye hospitals across India and internationally. The brand Dr. Agarwal's Eye Hospital is one of the most recognizable names in the Indian healthcare sector, particularly in eye care.

Here's an overview of Dr. Agarwal’s Health Care Ltd and its upcoming IPO:

Business Profile

  • Industry: Healthcare (Ophthalmology)
  • Services: Eye care services including cataract surgeries, laser vision correction, retina care, and general eye care.
  • Network: DAHCL operates a network of hospitals and clinics across India and in some international locations.
  • Reputation: Dr. Agarwal’s Eye Hospital has built a strong reputation in the field of eye care over several decades, under the leadership of Dr. Jagat Agarwal and other professionals.

IPO Details

  • Purpose of the IPO: The company plans to raise funds through the IPO to:
    1. Repay or prepay certain borrowings.
    2. Finance its expansion and growth initiatives.
    3. Strengthen its balance sheet.
  • IPO Size: As of now, the company has filed for an IPO of approximately INR 2,000 crores (this figure may vary depending on the final offer).
  • Price Band: The price band for the IPO is expected to be released in the future as the offer approaches. The company will finalize the price after consultation with book-running lead managers and underwriters.
  • Offer Type: The IPO may consist of a combination of fresh issue (new shares being issued) and an offer for sale (existing shareholders selling their shares).
  • Listing: The shares are expected to be listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).
  • Lead Managers: The IPO is being managed by prominent investment banks and financial institutions, which will handle the underwriting and marketing.

Financial Overview

Dr. Agarwal’s Health Care has shown steady financial performance, and the IPO will likely offer an insight into the company’s revenue, profit growth, and future outlook. A detailed prospectus will be available for investors which includes the company’s historical financials, revenue from operations, net profit margins, and any potential risks.

Growth Potential

Given the rising demand for eye care services in India and globally, Dr. Agarwal's Health Care has strong growth potential. The increasing awareness of eye health and the growing geriatric population in India present a good opportunity for the company’s expansion.

Risk Factors

Some potential risks that may be outlined in the company's prospectus include:

  • Competition in the healthcare industry.
  • Regulatory risks concerning healthcare practices.
  • Operational risks, including maintaining quality across a large network of hospitals.

International Presence

Dr. Agarwal's Eye Hospital also operates internationally in several countries, expanding its brand presence and tapping into global markets.

IPO Timeline

The exact dates of the IPO are yet to be disclosed, but the company has filed its draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (SEBI). The final offer details, including the price band and issue dates, will be revealed after SEBI approval.

How to Participate in the IPO: If you are interested in subscribing to Dr. Agarwal’s Health Care IPO, you will need to:

  1. Have a Demat and Trading account.
  2. Check the IPO application process and ensure you apply within the designated application window.
  3. Understand the allotment process, as IPO shares are usually allotted via a lottery system.

IPO Dates

Important dates with respect to IPO allotment and listing

  • Offer Starts

    29 Jan 2025

  • Offer Ends

    31 Jan 2025

  • Allotment

    03 Feb 2025

  • Listing

    05 Feb 2025













































Financial Trend

(in Crores)FY'22FY’23FY’24
Total Income7131,0311,376
PAT4310395
Total Assets1,0261,8252,752
Net Worth2126271,337
Borrowing290356387



Shareholding Pattern

ParticularsPre-IssuePost-Issue
Promoter37.17%31.98%
Promoter Group0.56%0.47%
Investor Selling Shareholders61.85%43.30%
Public - Others0.42%24.25%
Total100%100%

Comments

Post a Comment

Popular posts from this blog

Privacy Policy for Finzbazaar

  Privacy Policy for Finzbazaar Privacy Policy Last updated: March 22, 2025 This Privacy Policy describes Our policies and procedures on the collection, use and disclosure of Your information when You use the Service and tells You about Your privacy rights and how the law protects You. We use Your Personal data to provide and improve the Service. By using the Service, You agree to the collection and use of information in accordance with this Privacy Policy. This Privacy Policy has been created with the help of the  Privacy Policy Generator . Interpretation and Definitions Interpretation The words of which the initial letter is capitalized have meanings defined under the following conditions. The following definitions shall have the same meaning regardless of whether they appear in singular or in plural. Definitions For the purposes of this Privacy Policy: Account  means a unique account created for You to access our Service or parts of our Service. Affiliate  means a...
Read more